科华生物：产品取得注册证，产品名称为“全自动化学发光免疫分析仪”

Group 1 - The core point of the article is that Kehua Bio-engineering Co., Ltd. has received a medical device registration certificate for its "Fully Automated Chemiluminescence Immunoassay Analyzer" from the Shaanxi Provincial Drug Administration [1] - Kehua Bio's revenue composition for the first half of 2025 is reported to be 100.0% from the biopharmaceutical sector [1] - As of the time of reporting, Kehua Bio has a market capitalization of 3.3 billion yuan [1]